- Home
- SPKL vs SCPH Comparison
SPKL vs SCPH Comparison
Compare SPKL & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPKL
- SCPH
- Stock Information
- Founded
- SPKL 2021
- SCPH 2013
- Country
- SPKL United States
- SCPH United States
- Employees
- SPKL N/A
- SCPH N/A
- Industry
- SPKL
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- SPKL
- SCPH Health Care
- Exchange
- SPKL Nasdaq
- SCPH Nasdaq
- Market Cap
- SPKL 174.6M
- SCPH 179.6M
- IPO Year
- SPKL 2023
- SCPH 2017
- Fundamental
- Price
- SPKL $10.66
- SCPH $3.38
- Analyst Decision
- SPKL
- SCPH Strong Buy
- Analyst Count
- SPKL 0
- SCPH 2
- Target Price
- SPKL N/A
- SCPH $15.00
- AVG Volume (30 Days)
- SPKL 44.7K
- SCPH 442.5K
- Earning Date
- SPKL 01-01-0001
- SCPH 11-13-2024
- Dividend Yield
- SPKL N/A
- SCPH N/A
- EPS Growth
- SPKL N/A
- SCPH N/A
- EPS
- SPKL 0.19
- SCPH N/A
- Revenue
- SPKL N/A
- SCPH $30,278,000.00
- Revenue This Year
- SPKL N/A
- SCPH $172.64
- Revenue Next Year
- SPKL N/A
- SCPH $131.43
- P/E Ratio
- SPKL $57.45
- SCPH N/A
- Revenue Growth
- SPKL N/A
- SCPH 303.87
- 52 Week Low
- SPKL $10.18
- SCPH $3.08
- 52 Week High
- SPKL $11.95
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- SPKL 61.06
- SCPH 44.62
- Support Level
- SPKL $10.63
- SCPH $3.27
- Resistance Level
- SPKL $10.66
- SCPH $3.58
- Average True Range (ATR)
- SPKL 0.02
- SCPH 0.19
- MACD
- SPKL 0.00
- SCPH 0.01
- Stochastic Oscillator
- SPKL 75.00
- SCPH 22.92
About SPKL Spark I Acquisition Corp.
Spark I Acquisition Corp is a Blank check company.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.